Novartis acquires Anthos' abelacimab for $925M upfront and up to $3.1B total, marking CEO Bill Meury's second major exit and ...
Irish specialist agribusiness group Clonbio is in line for a €48.4 million European Union grant for a pioneering carbon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback